Posted by Michael Wonder on 10 Mar 2020
White House principles for reducing drug costs
10 March 2020 - In our partisan times, an opportunity for lawmakers to work across the aisle and get something done.
A divided Congress in a presidential election year may seem an unlikely setting for the first major drug-pricing reform in decades, but over the past year common goals and designs have emerged to set up a rare opportunity.
President Trump in his State of the Union address called on both parties to “get something on drug pricing done, done quickly, and done properly.” During times when our country faces public health challenges, America’s strength in pharmaceutical innovation is recognised as an asset we must employ.
